Augmedix Inc

Company Profile

Augmedix Inc had its IPO on 2021-03-31 under the ticker symbol AUGX.

The company operates in the Healthcare sector and Health Information Services industry. Augmedix Inc has a staff strength of 1,040 employees.

Stock update

Shares of Augmedix Inc opened at $4.91 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.89 - $5.03, and closed at $4.94.

This is a +0.82% increase from the previous day's closing price.

A total volume of 64,237 shares were traded at the close of the day’s session.

In the last one week, shares of Augmedix Inc have slipped by -1.59%.

Augmedix Inc's Key Ratios

Augmedix Inc has a market cap of $163.52 million, indicating a price to book ratio of 6.6729 and a price to sales ratio of 1.4967.

In the last 12-months Augmedix Inc’s revenue was $33.58 million with a gross profit of $13.95 million and an EBITDA of $-20970000. The EBITDA ratio measures Augmedix Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Augmedix Inc’s operating margin was -65.32% while its return on assets stood at -34.55% with a return of equity of -315.76%.

In Q1, Augmedix Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 37.8%.

Augmedix Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.7 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Augmedix Inc’s profitability.

Augmedix Inc stock is trading at a EV to sales ratio of 1.1775 and a EV to EBITDA ratio of -1.5693. Its price to sales ratio in the trailing 12-months stood at 1.4967.

Augmedix Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$33.64 million

Total Liabilities

$8.82 million

Operating Cash Flow

$-173000.00

Capital Expenditure

$592000

Dividend Payout Ratio

0%

Augmedix Inc ended 2024 with $33.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $33.64 million while shareholder equity stood at $1.47 million.

Augmedix Inc ended 2024 with $0 in deferred long-term liabilities, $8.82 million in other current liabilities, 4000.00 in common stock, $-125791000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $21.99 million and cash and short-term investments were $21.99 million. The company’s total short-term debt was $4,622,000 while long-term debt stood at $12.35 million.

Augmedix Inc’s total current assets stands at $28.34 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $6.35 million compared to accounts payable of $1.56 million and inventory worth $0.

In 2024, Augmedix Inc's operating cash flow was $-173000.00 while its capital expenditure stood at $592000.

Comparatively, Augmedix Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$4.94

52-Week High

$4.36

52-Week Low

$1.01

Analyst Target Price

$6.38

Augmedix Inc stock is currently trading at $4.94 per share. It touched a 52-week high of $4.36 and a 52-week low of $4.36. Analysts tracking the stock have a 12-month average target price of $6.38.

Its 50-day moving average was $4.6 and 200-day moving average was $2.89 The short ratio stood at 0.1 indicating a short percent outstanding of 0%.

Around 802.8% of the company’s stock are held by insiders while 7673.7% are held by institutions.